Welcome to our dedicated page for Qiagen SEC filings (Ticker: QGEN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QIAGEN N.V. filings document the reporting of a Netherlands-based foreign private issuer with common shares traded under QGEN. Its Form 20-F and Form 6-K disclosures cover audited annual financial statements, U.S. GAAP quarterly reports, operating and financial review, market-risk disclosures, legal proceedings, risk factors and the use of adjusted non-GAAP measures.
The filing record also includes exhibits and current reports tied to QIAGEN’s molecular diagnostics and life sciences portfolio, including sample technologies, QuantiFERON, QIAstat-Dx, QIAcuity and QIAGEN Digital Insights. Other disclosures address capital-structure actions such as a synthetic share repurchase and reverse stock split, material agreements, governance matters, exchange-listing registration notices and shareholder-facing corporate updates.